Aclarion Inc
NASDAQ:ACON

Watchlist Manager
Aclarion Inc Logo
Aclarion Inc
NASDAQ:ACON
Watchlist
Price: 3.55 USD 4.72% Market Closed
Market Cap: $8.1m

Aclarion Inc
Total Current Assets

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Aclarion Inc
Total Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Aclarion Inc
NASDAQ:ACON
Total Current Assets
$820k
CAGR 3-Years
-22%
CAGR 5-Years
53%
CAGR 10-Years
N/A
Veeva Systems Inc
NYSE:VEEV
Total Current Assets
$8B
CAGR 3-Years
26%
CAGR 5-Years
28%
CAGR 10-Years
32%
Inspire Medical Systems Inc
NYSE:INSP
Total Current Assets
$583.7m
CAGR 3-Years
3%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Doximity Inc
NYSE:DOCS
Total Current Assets
$1.1B
CAGR 3-Years
6%
CAGR 5-Years
55%
CAGR 10-Years
N/A
Omnicell Inc
NASDAQ:OMCL
Total Current Assets
$680.1m
CAGR 3-Years
-8%
CAGR 5-Years
-4%
CAGR 10-Years
10%
W
Waystar Holding Corp
NASDAQ:WAY
Total Current Assets
$308.4m
CAGR 3-Years
12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Aclarion Inc
Glance View

Market Cap
8.1m USD
Industry
Health Care

Aclarion Inc is a US-based company operating in Health Care Technology industry. The company is headquartered in San Mateo, California. The company went IPO on 2022-04-22. Aclarion, Inc. is a healthcare technology company that employs magnetic resonance spectroscopy (MRS) and artificial intelligence (AI) technology to optimize clinical treatments. The Company’s technology is focused on improving surgical decision making when surgical intervention is being contemplated for patients with low back pain. Its first commercial product, NOCISCAN-LS, utilizes its proprietary biomarkers and algorithms to provide surgeons with information about which intervertebral discs are determined to be consistent with generating pain, and which are not. NOCISCAN is a software as a service (SaaS) platform to leverage MRS to non-invasively help physicians distinguish between painful and nonpainful discs in the spine. The platform used to conduct a NOCISCAN-LS involves NOCISCAN-LS MRS exam protocol, data transfer, and the NOCISCAN-LS post-processor suite. The Company’s NOCISCAN-LS post processor suite is comprised of two software products, such as NOCICALC-LS and NOCIGRAM.

ACON Intrinsic Value
LOCKED
Unlock

See Also

What is Aclarion Inc's Total Current Assets?
Total Current Assets
820k USD

Based on the financial report for Dec 31, 2025, Aclarion Inc's Total Current Assets amounts to 820k USD.

What is Aclarion Inc's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
53%

Over the last year, the Total Current Assets growth was 0%. The average annual Total Current Assets growth rates for Aclarion Inc have been -22% over the past three years , 53% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett